Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors

Indini, A; Rijavec, E; Ghidini, M; Cortellini, A; Grossi, F

Grossi, F (corresponding author), Univ Insubria, Dept Med & Surg, Med Oncol Unit, ASST Sette Laghi, I-21100 Varese, Italy.

PHARMACEUTICS, 2021; 13 (5):

Abstract

Activating mutations in RAS family proteins are found in similar to 25% of all human cancers. Different solid tumors are correlated with mutations in ......

Full Text Link